Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
Clinical and Applied Thrombosis/Hemostasis · 2023-01 · 29
DOI: 10.1177/10760296231193398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 10.08.2023. Verfasst von Shosaku Nomura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Thrombosis and Hemostasis, Kansai Medical University Medical Center, Moriguchi, Japan. Hauptthemen laut MEDLINE: HMGB1 Protein, Hematopoietic Stem Cell Transplantation, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Mobilisation
Abstract (Originalsprache)
Thrombotic complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT) significantly impact transplant outcomes. We focused on high mobility group box-protein (HMGB)1, one causative agent of thrombotic lesions in allo-HSCT, and investigated its association with platelets. We statistically analyzed available data from 172 patients with hematopoietic malignancies receiving allo-HSCT. A significant enhancement of monocyte-chemotactant protein-1, HMGB1, and platelet-derived microparticle (PDMP) levels was observed at day 0 after transplantation as compared to pre-transplantation. Multivariate analysis of the association among HMGB1 and 16 factors on day 0 revealed a significant correlation of HMGB1 levels with thrombin–antithrombin complex, interleukin-6, and PDMPs. High mobility group box-protein 1-induced procoagulant platelet induction and PDMP generation were performed in vitro using healthy platelets. High mobility group box-protein 1-induced PDMP generation was suppressed by toll-like receptor inhibitors and recombinant thrombomodulin. These results suggest that HMGB1 contributes to platelet activation in patients after allo-HSCT and is associated with PDMP-related thrombotic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Thrombosis and Hemostasis, Kansai Medical University Medical Center, Moriguchi, Japan.
- First Department of Internal Medicine, Kansai Medical University Medical Center, Moriguchi, Japan.
- First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
ORCID-Profile: Shosaku Nomura
Zitieren
APA
Nomura, S., Ichikawa, J., Shimizu, T., Ishiura, Y., Okada, M., Ishii, K., & Ito, T. (2023). Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation. Clinical and Applied Thrombosis/Hemostasis, 29. https://doi.org/10.1177/10760296231193398
Vancouver
Nomura S, Ichikawa J, Shimizu T, Ishiura Y, Okada M, Ishii K, et al. Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation. Clinical and Applied Thrombosis/Hemostasis. 2023;29. doi:10.1177/10760296231193398
BibTeX
@article{Nomura2023,
author = {Nomura, Shosaku and Ichikawa, Jun and Shimizu, Toshiki and Ishiura, Yoshihisa and Okada, Masaya and Ishii, Kazuyoshi and Ito, Tomoki},
title = {Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2023},
volume = {29},
doi = {10.1177/10760296231193398}
}
EUVIMED